Sign in
4

Changes in Ownership

ALX ONCOLOGY HOLDINGS INC Filed Acc 0001415889-24-008260

CHIEF EXECUTIVE OFFICER bought 4,400 shares at $11.31 ($49,771)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lettmann Jason CHIEF EXECUTIVE OFFICER 2024-03-14 Purchase +4,400 $11.31 $49,771 171,620 D
Open-market purchases · 4,400 sh · avg $11.31 · $49,771
Loading xslF345X05/form4-03182024_080318.xml…